Zhenbaodao (603567.SH): Mabalo Shawei (Baloxavir Marboxil) chemical API approved for marketing

Zhitong Finance APP News, Zhenbaodao (603567.SH) announced that recently, the company's Jixi Branch received the "Chemical API Marketing Application Approval Notice" for Baloxavir Marboxil issued by the National Medical Products Administration. Baloxavir Marboxil Tablets are indicated for adult and pediatric patients aged 5 years and older with acute uncomplicated influenza A and B, including previously healthy patients and those at high risk of influenza-related complications. Baloxavir Marboxil for Oral Suspension is indicated for pediatric patients aged 1 to less than 12 years with acute uncomplicated influenza A and B, including previously healthy patients and those at high risk of influenza complications.